Top compounds associated with response to RNPC3


Feature Type Standardized
Nominal ANOVA
mRNA dabrafenib CTRPv2 pan-cancer AAC -0.045 0.4
mRNA fulvestrant CTRPv2 pan-cancer AAC 0.069 0.4
mRNA BX-795 GDSC1000 pan-cancer AAC 0.033 0.4
mRNA lenvatinib CTRPv2 pan-cancer AAC 0.034 0.4
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.03 0.4
mRNA AZD0530 CCLE pan-cancer AAC 0.044 0.4
mRNA Axitinib CTRPv2 pan-cancer AAC 0.031 0.4
mRNA BRD-A71883111 CTRPv2 pan-cancer AAC 0.034 0.4
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.034 0.4
mRNA Erlotinib CCLE pan-cancer AAC 0.042 0.4
Download CSV